St. Michael's Hospital, Toronto, Canada.
University of Toronto, Toronto, Canada.
Nutr Rev. 2019 Jan 1;77(1):19-31. doi: 10.1093/nutrit/nuy040.
Current dietary guidelines for cardiovascular disease risk management recommend restricting intake of saturated fatty acids (SFAs). However, the optimal macronutrient profile, in the context of a low-SFA diet, remains controversial. The blood-pressure effect of replacing SFAs in diets with monounsaturated fatty acids (MUFAs) compared with carbohydrate has not been quantified to date.
To synthesize the evidence for the effect of substituting a high-carbohydrate (high-CHO) diet for a high-monounsaturated fatty acid (high-MUFA) diet on blood pressure, a systematic review and meta-analysis of randomized clinical trials in a population without health restrictions was conducted.
MEDLINE, EMBASE, and Cochrane Central Register of Controlled Clinical Trials were searched through June 7, 2017. Randomized controlled trials of > 3 weeks duration that assessed the effect of high-MUFA diets in isocaloric substitution for high-CHO diets on systolic blood pressure (SBP) and diastolic blood pressure (DBP) were included.
Data were pooled using the generic-inverse variance method with random effects models and expressed as mean differences (MDs) with 95% confidence intervals (CIs). Heterogeneity was assessed by Cochran Q statistic and quantified by the I2 statistic. The quality of the evidence was assessed with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system.
Fourteen trials (n = 980 participants) were included in the analysis. Comparatively, the high-MUFA diets in isocaloric substitution for high-CHO diets did not demonstrate a greater reduction in blood pressure (SBP: MD, -0.08 mmHg [95%CI, -1.01 to 0.84], P = 0.86; DBP: MD = 0.01 mmHg [95%CI, -0.73 to 0.75], P = 0.98). The overall quality of the evidence was assessed as moderate.
In the context of low SFAs, high-MUFA diets in isocaloric substitution for high-CHO diets did not affect blood pressure in individuals with and without hypertension. Large-scale trials achieving higher MUFA targets are required to support these findings.
CLINICALTRIALS.GOV ID: NCT02626325.
目前心血管疾病风险管理的饮食指南建议限制饱和脂肪酸(SFA)的摄入量。然而,在低 SFA 饮食的情况下,最佳的宏量营养素谱仍存在争议。与碳水化合物相比,用单不饱和脂肪酸(MUFA)代替饮食中的 SFA 对血压的影响迄今尚未量化。
本系统评价和荟萃分析旨在综合评估用高碳水化合物(高 CHO)饮食代替高单不饱和脂肪酸(高 MUFA)饮食对血压的影响,纳入的是在没有健康限制的人群中进行的、为期超过 3 周的随机临床试验。
通过 2017 年 6 月 7 日检索 MEDLINE、EMBASE 和 Cochrane 对照临床试验中心注册库。纳入的试验为评估高 MUFA 饮食在等热量替代高 CHO 饮食对收缩压(SBP)和舒张压(DBP)影响的、持续时间超过 3 周的随机对照试验。
使用固定效应模型的通用逆方差法对数据进行汇总,并表示为均数差值(MD)及其 95%置信区间(CI)。用 Cochran Q 统计量评估异质性,并以 I2 统计量表示。证据质量采用推荐评估、制定与评价(GRADE)系统评估。
分析纳入了 14 项试验(n=980 名参与者)。相比之下,高 MUFA 饮食在等热量替代高 CHO 饮食中并未显示出血压更大幅度的降低(SBP:MD,-0.08mmHg[95%CI,-1.01 至 0.84],P=0.86;DBP:MD=0.01mmHg[95%CI,-0.73 至 0.75],P=0.98)。证据的总体质量评估为中等。
在低 SFA 的情况下,高 MUFA 饮食在等热量替代高 CHO 饮食中对高血压和非高血压个体的血压均无影响。需要进行大规模试验以实现更高的 MUFA 目标,从而支持这些发现。
临床试验.gov 注册号:NCT02626325。